Pharma & Healthcare
Global Dengue Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 25, 25
- ID: 338451
- Pages: 109
- Figures: 115
- Views: 3
In 2024, the global market size of Dengue Vaccines was estimated to be worth US$ 524 million and is forecast to reach approximately US$ 1317 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Sanofi
Takeda
Segment by Type
Dengvaxia
TAK-003
Others
Segment by Application
Public Sector
Private Sector
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Dengue Vaccines in global and regional level.
Chapter 3: Detailed analysis of Dengue Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dengue Vaccines revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Sanofi
Takeda
Segment by Type
Dengvaxia
TAK-003
Others
Segment by Application
Public Sector
Private Sector
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Dengue Vaccines in global and regional level.
Chapter 3: Detailed analysis of Dengue Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dengue Vaccines revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Dengue Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Dengvaxia
1.2.3 TAK-003
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dengue Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccines Market Size Estimates and Forecasts
2.2 Dengue Vaccines Market Size by Region: 2024 Versus 2031
2.2.1 Global Dengue Vaccines Revenue by Region: 2020-2025
2.2.2 Global Dengue Vaccines Revenue Forecast by Region (2026-2031)
2.2.3 Global Dengue Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Dengue Vaccines Revenue by Type (2020-2031)
3.1.2 Global Dengue Vaccines Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Dengue Vaccines Revenue by Application (2020-2031)
3.2.2 Global Dengue Vaccines Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Dengvaxia of Dengue Vaccines Revenue Market Share by Application
3.3.2 TAK-003 of Dengue Vaccines Revenue Market Share by Application
3.3.3 Others of Dengue Vaccines Revenue Market Share by Application
4 Global Dengue Vaccines by Company
4.1 Global Dengue Vaccines Revenue by Company (2020-2025)
4.2 Global Dengue Vaccines Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Dengue Vaccines Companies around the World: Ranking by Revenue
4.3.2 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Dengue Vaccines Companies Headquarters & Product Type
4.4.1 Global Dengue Vaccines Companies Headquarters
4.4.2 Date of International Companies Enter into Dengue Vaccines Market
4.4.3 Global Dengue Vaccines Companies Product & Service
4.4.4 Dengvaxia Revenue Market Share of Dengue Vaccines by Company
4.5 Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Corporation Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Dengue Vaccines Products Offered
5.1.4 Sanofi Dengue Vaccines Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Dengue Vaccines Revenue by Product in 2024
5.1.6 Sanofi Dengue Vaccines Revenue by Application in 2024
5.1.7 Sanofi Dengue Vaccines Revenue by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 Takeda
5.2.1 Takeda Corporation Information
5.2.2 Takeda Description, Business Overview
5.2.3 Takeda Dengue Vaccines Products Offered
5.2.4 Takeda Dengue Vaccines Revenue and Gross Margin (2020-2025)
5.2.5 Takeda Dengue Vaccines Revenue by Product in 2024
5.2.6 Takeda Dengue Vaccines Revenue by Application in 2024
5.2.7 Takeda Dengue Vaccines Revenue by Geographic Area in 2024
5.2.8 Takeda Recent Developments
6 North America
6.1 North America Dengue Vaccines Market Size YoY Growth 2020-2031
6.2 North America Dengue Vaccines Market Facts & Figures by Country (2020-2031)
6.3 North America Dengue Vaccines Revenue by Type (2020-2025)
6.4 North America Dengue Vaccines Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Dengue Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Dengue Vaccines Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025)
7.4 Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025)
8 Europe
8.1 Europe Dengue Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Dengue Vaccines Market Facts & Figures by Country (2020-2031)
8.3 Europe Dengue Vaccines Revenue by Type (2020-2025)
8.4 Europe Dengue Vaccines Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Dengue Vaccines Market Facts & Figures by Country (2020-2031)
9.3 Latin America Dengue Vaccines Revenue by Type (2020-2025)
9.4 Latin America Dengue Vaccines Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Dengue Vaccines Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025)
10.4 Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Dengue Vaccines Supply Chain Analysis
11.2 Dengue Vaccines Key Raw Materials and Upstream Suppliers
11.3 Dengue Vaccines Clients Analysis
11.4 Dengue Vaccines Sales Channel and Sales Model Analysis
11.4.1 Dengue Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Dengue Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Dengue Vaccines Distributors
12 Dengue Vaccines Market Dynamics
12.1 Dengue Vaccines Industry Trends
12.2 Dengue Vaccines Market Drivers
12.3 Dengue Vaccines Market Challenges
12.4 Dengue Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Dengue Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Dengvaxia
1.2.3 TAK-003
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dengue Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccines Market Size Estimates and Forecasts
2.2 Dengue Vaccines Market Size by Region: 2024 Versus 2031
2.2.1 Global Dengue Vaccines Revenue by Region: 2020-2025
2.2.2 Global Dengue Vaccines Revenue Forecast by Region (2026-2031)
2.2.3 Global Dengue Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Dengue Vaccines Revenue by Type (2020-2031)
3.1.2 Global Dengue Vaccines Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Dengue Vaccines Revenue by Application (2020-2031)
3.2.2 Global Dengue Vaccines Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Dengvaxia of Dengue Vaccines Revenue Market Share by Application
3.3.2 TAK-003 of Dengue Vaccines Revenue Market Share by Application
3.3.3 Others of Dengue Vaccines Revenue Market Share by Application
4 Global Dengue Vaccines by Company
4.1 Global Dengue Vaccines Revenue by Company (2020-2025)
4.2 Global Dengue Vaccines Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Dengue Vaccines Companies around the World: Ranking by Revenue
4.3.2 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Dengue Vaccines Companies Headquarters & Product Type
4.4.1 Global Dengue Vaccines Companies Headquarters
4.4.2 Date of International Companies Enter into Dengue Vaccines Market
4.4.3 Global Dengue Vaccines Companies Product & Service
4.4.4 Dengvaxia Revenue Market Share of Dengue Vaccines by Company
4.5 Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Corporation Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Dengue Vaccines Products Offered
5.1.4 Sanofi Dengue Vaccines Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Dengue Vaccines Revenue by Product in 2024
5.1.6 Sanofi Dengue Vaccines Revenue by Application in 2024
5.1.7 Sanofi Dengue Vaccines Revenue by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 Takeda
5.2.1 Takeda Corporation Information
5.2.2 Takeda Description, Business Overview
5.2.3 Takeda Dengue Vaccines Products Offered
5.2.4 Takeda Dengue Vaccines Revenue and Gross Margin (2020-2025)
5.2.5 Takeda Dengue Vaccines Revenue by Product in 2024
5.2.6 Takeda Dengue Vaccines Revenue by Application in 2024
5.2.7 Takeda Dengue Vaccines Revenue by Geographic Area in 2024
5.2.8 Takeda Recent Developments
6 North America
6.1 North America Dengue Vaccines Market Size YoY Growth 2020-2031
6.2 North America Dengue Vaccines Market Facts & Figures by Country (2020-2031)
6.3 North America Dengue Vaccines Revenue by Type (2020-2025)
6.4 North America Dengue Vaccines Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Dengue Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Dengue Vaccines Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025)
7.4 Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025)
8 Europe
8.1 Europe Dengue Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Dengue Vaccines Market Facts & Figures by Country (2020-2031)
8.3 Europe Dengue Vaccines Revenue by Type (2020-2025)
8.4 Europe Dengue Vaccines Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Dengue Vaccines Market Facts & Figures by Country (2020-2031)
9.3 Latin America Dengue Vaccines Revenue by Type (2020-2025)
9.4 Latin America Dengue Vaccines Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Dengue Vaccines Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025)
10.4 Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Dengue Vaccines Supply Chain Analysis
11.2 Dengue Vaccines Key Raw Materials and Upstream Suppliers
11.3 Dengue Vaccines Clients Analysis
11.4 Dengue Vaccines Sales Channel and Sales Model Analysis
11.4.1 Dengue Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Dengue Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Dengue Vaccines Distributors
12 Dengue Vaccines Market Dynamics
12.1 Dengue Vaccines Industry Trends
12.2 Dengue Vaccines Market Drivers
12.3 Dengue Vaccines Market Challenges
12.4 Dengue Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Dengue Vaccines Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Dengue Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Dengue Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dengue Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Dengue Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Dengue Vaccines Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Dengue Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 11. Dengue Vaccines Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Dengue Vaccines Players by Revenue (US$ Million) in 2024
Table 13. Global Dengue Vaccines Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2024)
Table 15. Global Dengue Vaccines Companies Headquarters
Table 16. Date of International Companies Enter into Dengue Vaccines Market
Table 17. Global Dengue Vaccines Companies Product & Service
Table 18. Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans
Table 19. Sanofi Corporation Information
Table 20. Sanofi Description and Business Overview
Table 21. Sanofi Dengue Vaccines Product
Table 22. Sanofi Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Sanofi Revenue Proportion of Dengue Vaccines by Product in 2024
Table 24. Sanofi Revenue Proportion of Dengue Vaccines by Application in 2024
Table 25. Sanofi Revenue Proportion of Dengue Vaccines by Geographic Area in 2024
Table 26. Sanofi Recent Developments
Table 27. Takeda Corporation Information
Table 28. Takeda Description and Business Overview
Table 29. Takeda Dengue Vaccines Product
Table 30. Takeda Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Takeda Revenue Proportion of Dengue Vaccines by Product in 2024
Table 32. Takeda Revenue Proportion of Dengue Vaccines by Application in 2024
Table 33. Takeda Revenue Proportion of Dengue Vaccines by Geographic Area in 2024
Table 34. Takeda Recent Developments
Table 35. North America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 36. North America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 37. North America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 38. North America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Dengue Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 43. Europe Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Europe Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Europe Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 46. Europe Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 47. Latin America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 48. Latin America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 49. Latin America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 50. Latin America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 53. Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 54. Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 55. Dengue Vaccines Key Raw Materials, Industry Status and Trend
Table 56. Dengue Vaccines Key Raw Materials and Upstream Suppliers
Table 57. Dengue Vaccines Clients Status and Trend
Table 58. Dengue Vaccines Typical Clients
Table 59. Dengue Vaccines Distributors
Table 60. Dengue Vaccines Market Trends
Table 61. Dengue Vaccines Market Drivers
Table 62. Dengue Vaccines Market Challenges
Table 63. Dengue Vaccines Market Restraints
Table 64. Research Programs/Design for This Report
Table 65. Key Data Information from Secondary Sources
Table 66. Key Data Information from Primary Sources
List of Figures
Figure 1. Dengue Vaccines Product Picture
Figure 2. Global Dengue Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Dengue Vaccines Revenue Market Share by Type in 2024 & 2031
Figure 4. Dengvaxia Product Picture
Figure 5. TAK-003 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dengue Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Dengue Vaccines Revenue Market Share by Application in 2024 & 2031
Figure 9. Public Sector
Figure 10. Private Sector
Figure 11. Dengue Vaccines Report Years Considered
Figure 12. Global Dengue Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Dengue Vaccines Market Size (2020-2031) & (US$ Million)
Figure 14. Global Dengue Vaccines Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Dengue Vaccines Revenue Market Share by Region (2020-2031)
Figure 16. Global Dengue Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Dengue Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Dengvaxia of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 19. TAK-003 of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 20. Others of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 21. Dengue Vaccines Revenue Share by Company (2024)
Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Dengvaxia Revenue Proportion by Company in 2024
Figure 24. TAK-003 Revenue Proportion by Company in 2024
Figure 25. Others Revenue Proportion by Company in 2024
Figure 26. North America Dengue Vaccines Revenue 2020-2031 (US$ Million)
Figure 27. North America Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 28. North America Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Dengue Vaccines Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Dengue Vaccines Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 33. Europe Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 35. Europe Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 36. Europe Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 45. Dengue Vaccines Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Dengue Vaccines Raw Materials by Region in 2024
Figure 47. Dengue Vaccines Distribution Channels
Figure 48. Global Dengue Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Dengue Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Dengue Vaccines Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Dengue Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Dengue Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dengue Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Dengue Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Dengue Vaccines Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Dengue Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 11. Dengue Vaccines Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Dengue Vaccines Players by Revenue (US$ Million) in 2024
Table 13. Global Dengue Vaccines Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2024)
Table 15. Global Dengue Vaccines Companies Headquarters
Table 16. Date of International Companies Enter into Dengue Vaccines Market
Table 17. Global Dengue Vaccines Companies Product & Service
Table 18. Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans
Table 19. Sanofi Corporation Information
Table 20. Sanofi Description and Business Overview
Table 21. Sanofi Dengue Vaccines Product
Table 22. Sanofi Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Sanofi Revenue Proportion of Dengue Vaccines by Product in 2024
Table 24. Sanofi Revenue Proportion of Dengue Vaccines by Application in 2024
Table 25. Sanofi Revenue Proportion of Dengue Vaccines by Geographic Area in 2024
Table 26. Sanofi Recent Developments
Table 27. Takeda Corporation Information
Table 28. Takeda Description and Business Overview
Table 29. Takeda Dengue Vaccines Product
Table 30. Takeda Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Takeda Revenue Proportion of Dengue Vaccines by Product in 2024
Table 32. Takeda Revenue Proportion of Dengue Vaccines by Application in 2024
Table 33. Takeda Revenue Proportion of Dengue Vaccines by Geographic Area in 2024
Table 34. Takeda Recent Developments
Table 35. North America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 36. North America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 37. North America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 38. North America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Dengue Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 43. Europe Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Europe Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Europe Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 46. Europe Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 47. Latin America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 48. Latin America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 49. Latin America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 50. Latin America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 53. Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 54. Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 55. Dengue Vaccines Key Raw Materials, Industry Status and Trend
Table 56. Dengue Vaccines Key Raw Materials and Upstream Suppliers
Table 57. Dengue Vaccines Clients Status and Trend
Table 58. Dengue Vaccines Typical Clients
Table 59. Dengue Vaccines Distributors
Table 60. Dengue Vaccines Market Trends
Table 61. Dengue Vaccines Market Drivers
Table 62. Dengue Vaccines Market Challenges
Table 63. Dengue Vaccines Market Restraints
Table 64. Research Programs/Design for This Report
Table 65. Key Data Information from Secondary Sources
Table 66. Key Data Information from Primary Sources
List of Figures
Figure 1. Dengue Vaccines Product Picture
Figure 2. Global Dengue Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Dengue Vaccines Revenue Market Share by Type in 2024 & 2031
Figure 4. Dengvaxia Product Picture
Figure 5. TAK-003 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dengue Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Dengue Vaccines Revenue Market Share by Application in 2024 & 2031
Figure 9. Public Sector
Figure 10. Private Sector
Figure 11. Dengue Vaccines Report Years Considered
Figure 12. Global Dengue Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Dengue Vaccines Market Size (2020-2031) & (US$ Million)
Figure 14. Global Dengue Vaccines Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Dengue Vaccines Revenue Market Share by Region (2020-2031)
Figure 16. Global Dengue Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Dengue Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Dengvaxia of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 19. TAK-003 of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 20. Others of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 21. Dengue Vaccines Revenue Share by Company (2024)
Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Dengvaxia Revenue Proportion by Company in 2024
Figure 24. TAK-003 Revenue Proportion by Company in 2024
Figure 25. Others Revenue Proportion by Company in 2024
Figure 26. North America Dengue Vaccines Revenue 2020-2031 (US$ Million)
Figure 27. North America Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 28. North America Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Dengue Vaccines Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Dengue Vaccines Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 33. Europe Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 35. Europe Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 36. Europe Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Dengue Vaccines Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Dengue Vaccines Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Dengue Vaccines Revenue Market Share by Application (2020-2025)
Figure 45. Dengue Vaccines Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Dengue Vaccines Raw Materials by Region in 2024
Figure 47. Dengue Vaccines Distribution Channels
Figure 48. Global Dengue Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Dengue Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232